Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide association study on overall survival of advanced non-small cell lung cancer patients treated with carboplatin and paclitaxel.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Jan 2011

Sato Yasunori, Yamamoto Noboru, Kunitoh Hideo, Ohe Yuichiro, Minami Hironobu, Laird Nan M, Katori Noriko, Saito Yoshiro, Ohnami Sumiko, Sakamoto Hiromi, Sawada Jun-Ichi, Saijo Nagahiro, Yoshida Teruhiko, Tamura Tomohide

Abstract excerpt

PURPOSE: Our goal was to identify candidate polymorphisms that could influence overall survival (OS) in advanced non-small cell lung cancer (NSCLC) patients treated with carboplatin (CBDCA) and paclitaxel (PTX). METHODS: Chemotherapy-naïve stage IIIB or IV NSCLC patients treated with CBDCA (area...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Carboplatin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Neoplasm Staging

Share to Paclitaxel

Share to Pharmacogenetics

Share to Survival Rate

Share to Tissue Distribution

Source

Identifiers

PMID: 21079520
DOI: 10.1097/JTO.0b013e318200f415

Genes

DSCAM
ETS2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21079520-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide association study on overall survival of advanced non-small cell lung cancer patients treated with carboplatin and paclitaxel.PMID 21079520Read ↗

Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.Semantic proximity Read ↗

Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.Semantic proximity Read ↗

A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.Semantic proximity Read ↗

Genome-wide analysis of survival in early-stage non-small-cell lung cancer.Semantic proximity Read ↗

Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Model for Assessing Population-Related PharmacogenomicsSemantic proximity Read ↗

Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy.Semantic proximity Read ↗

Using Whole-Exome Sequencing to Identify Genetic Markers for Carboplatin and Gemcitabine-Induced Toxicities.Semantic proximity Read ↗

Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.Semantic proximity Read ↗

Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer.Semantic proximity Read ↗

A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer.Semantic proximity Read ↗

MicroRNA-binding site SNPs in deregulated genes are associated with clinical outcome of non-small cell lung cancer.Semantic proximity Read ↗

Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.